Is Green Thumb Stock Oversold? The Case for 100% Upside
Could Green Thumb Industries be trading below its true value? This guide weighs the fundamentals, catalysts, and risk...
On this tag page you will get three Cannabis Stocks analyses, including Canopy Growth and Tilray notes, with practical takeaways for risk and portfolio diversification.
21 articlesCould Green Thumb Industries be trading below its true value? This guide weighs the fundamentals, catalysts, and risk...
Regulators are moving toward rescheduling cannabis, with a fast-tracked DEA hearing underway and a potential tax reli...
Investors are watching canopy growth's medical marijuana as a potential engine for a rebound. This guide breaks down ...
Investors are scanning cannabis names for growth and resilience. Here are three clear reasons why Green Thumb Industr...
When a CEO sells a sizable chunk of stock, investors take notice. This article dives into the details behind trulieve...
A major moment for cannabis investing has arrived. A U.S. cannabis company began trading on a flagship exchange, sign...
Tilray is expanding beyond its home market, but the stock market isn’t fully pricing in that growth. This article bre...
A landmark listed on the NYSE signals bigger access to capital and greater scrutiny for cannabis companies. Learn how...
Canopy Growth just made a bold move aimed at turning around years of underperformance. This article breaks down the d...
Two giants in the U.S. cannabis space face off for investors: Green Thumb Industries and Curaleaf. This guide breaks ...
Tilray has cleared several hurdles, but a true breakout depends on one pivotal development. This guide breaks down th...
Canopy Growth is restating two years of earnings ahead of June earnings. This article breaks down what it means, how ...